One of our favorite bio-celebrities is enlarging his CV with a new job position. The German-Canadian Chris Viehbacher will run the billionaire Gurnet Point Capital fund, owned by the Swiss magnate Ernesto Bertarelli.
If Chris Viehbacher felt disappointed after being dumped from Sanofi, at least he didn’t lose his pharma thrill. Recently, however, the business man steped a bit further aside from the labs since he is now focusing on healthcare investments. In March, Viehbacher joined PureTech Ventures‘ Board of directors, a Boston-based company that raised about €150M in an IPO on the London exchange market earlier this month.
Now, the former CEO of Sanofi has added another job to his prolific career. Swiss billionaire Ernesto Bertarelli has hired Viehbacher to run Gurnet Point Capital fund. The entrepreneur will lead the fund’s global investment strategy, with an initial allocation of €1.8Bn exclusively dedicated to life sciences.
Viehbacher will continue being headquartered in Boston, his beloved city from where he tried to manage the largest French pharma.